Informationen zum Autor Swapnil Gupta, MBBS, MD Assistant Professor, Department of Psychiatry, Yale University School of Medicine;John D. Cahill, BMBS, PhD, , Assistant Professor, Department of Psychiatry, Yale University School of Medicine; Rebecca Miller, PhD, Assistant Professor, Department of Psychiatry, Yale University School of Medicine Klappentext Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. This book describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It outlines the how and when, and gives recommendations on what the prescriber and patient may encounter along the way. Zusammenfassung The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits.Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour.As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice. Inhaltsverzeichnis Preface Chapter 1 Introduction Chapter 2 Decision making in deprescribing Chapter 3 Barriers to deprescribing Chapter 4 Non pharmacological considerations Chapter 5 Wellness approaches I: Self-determined strategies Chapter 6 Wellness approaches II: Collaborative strategies Chapter 7 Process of deprescribing Chapter 8 Deprescribing antidepressant medications Chapter 9 Deprescribing antipsychotic medications Chapter 10 Deprescribing mood stabilizers medications Chapter 11 Deprescribing benzodiazepine and stimulants Chapter 12 Conclusions and future directions Afterword ...

Klappentext

Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. This book describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It outlines the how and when, and gives recommendations on what the prescriber and patient may encounter along the way.

Zusammenfassung
The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits. Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour. As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.

Inhalt

• Preface
• Chapter 1 Introduction
• Chapter 2 Decision making in deprescribing
• Chapter 3 Barriers to deprescribing
• Chapter 4 Non pharmacological considerations
• Chapter 5 Wellness approaches I: Self-determined strategies
• Chapter 6 Wellness approaches II: Collaborative strategies
• Chapter 7 Process of deprescribing
• Chapter 8 Deprescribing antidepressant medications
• Chapter 9 Deprescribing antipsychotic medications
• Chapter 10 Deprescribing mood stabilizers medications
• Chapter 11 Deprescribing benzodiazepine and stimulants
• Chapter 12 Conclusions and future directions
• Afterword